The use of urokinase, pyridinolcarbamate, and dypiridamole in rat heart allografts.
D000818:Animals; D000961:Antilymphocyte Serum; D002219:Carbamates / Q000627:therapeutic use*; D003331:Coronary Vessels / Q000187:drug effects; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006084:Graft Rejection / Q000187:drug effects*; D006339:Heart Rate; D016027:Heart Transplantation; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000432:Methanol / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011817:Rabbits / Q000276:immunology; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D002219:Carbamates; D005343:Fibrinolytic Agents; D007166:Immunosuppressive Agents; D011725:Pyridines; D004176:Dipyridamole; D000432:Methanol